• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Arcosa Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    5/6/25 4:20:08 PM ET
    $ACA
    Metal Fabrications
    Industrials
    Get the next $ACA alert in real time by email
    aca-20250506
    0001739445false00017394452025-05-062025-05-06

    UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    WASHINGTON, D.C. 20549
    FORM 8-K
    CURRENT REPORT
    Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
    Date of Report (Date of Earliest Event Reported): May 6, 2025

    arcosalogo-orangea13.jpg
    Arcosa, Inc.
    __________________________________________
    (Exact name of registrant as specified in its charter)
    Delaware1-3849482-5339416
    (State or other jurisdiction of incorporation)(Commission File Number)(I.R.S. Employer Identification No.)
        
    500 N. Akard Street, Suite 400
    Dallas,Texas75201
    (Address of principal executive offices) (Zip Code)

    Registrant's telephone number, including area code: (972) 942-6500
    Not Applicable
    (Former name or former address, if changed since last report)

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
    ☐  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
    ☐  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
    ☐  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
    ☐  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
    Securities registered pursuant to Section 12(b) of the Act:
    Title of each classTrading Symbol(s)Name of each exchange on which registered
    Common Stock ($0.01 par value)ACANew York Stock Exchange
    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
    Emerging growth company ☐
    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐




    Item 2.02     Results of Operation and Financial Condition.
    Attached as Exhibit 99.1 is the registrant’s earnings release for the first quarter of 2025, issued May 6, 2025. This release is being furnished and shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise incorporated by reference into any filing pursuant to the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, except as otherwise expressly stated in such filing.
    Item 9.01     Financial Statements and Exhibits.
    (d) Exhibits
    Exhibit No.Description
    99.1
    Arcosa, Inc. Earnings Release, dated May 6, 2025.
    104Cover Page Interactive Data File (embedded within the Inline XBRL document)




    SIGNATURES

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

    Arcosa, Inc.
    (Registrant)
    May 6, 2025
    By:/s/ Gail M. Peck
    Name: Gail M. Peck
    Title: Chief Financial Officer


    Get the next $ACA alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $ACA

    DatePrice TargetRatingAnalyst
    10/29/2024$106.00Overweight
    Barclays
    8/7/2024$96.00Equal-Weight → Overweight
    Stephens
    10/17/2023$90.00Neutral → Buy
    Sidoti
    11/8/2022$75.00 → $65.00Overweight → Equal-Weight
    Stephens
    11/2/2021$63.00Buy
    Loop Capital
    10/5/2021$63.00Buy
    Berenberg
    9/7/2021$60.00Overweight
    Stephens
    7/26/2021$66.00Neutral → Buy
    Sidoti
    More analyst ratings